

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.83623232 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.15428709 |
| 3 | detection of molecule of bacterial origin (GO:0032490) | 4.94975339 |
| 4 | detection of other organism (GO:0098543) | 4.87108204 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.68202881 |
| 6 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.55917628 |
| 7 | detection of external biotic stimulus (GO:0098581) | 4.45616724 |
| 8 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.44637884 |
| 9 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.38851093 |
| 10 | negative regulation of cell killing (GO:0031342) | 4.38851093 |
| 11 | detection of bacterium (GO:0016045) | 4.37736031 |
| 12 | negative thymic T cell selection (GO:0045060) | 4.29550935 |
| 13 | negative regulation of interleukin-12 production (GO:0032695) | 4.29219709 |
| 14 | negative T cell selection (GO:0043383) | 4.25533137 |
| 15 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.17522185 |
| 16 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.17522185 |
| 17 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.11882438 |
| 18 | response to host immune response (GO:0052572) | 4.10787779 |
| 19 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.10787779 |
| 20 | macrophage activation (GO:0042116) | 4.02451821 |
| 21 | detection of biotic stimulus (GO:0009595) | 3.94455330 |
| 22 | B cell receptor signaling pathway (GO:0050853) | 3.94453897 |
| 23 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.82963197 |
| 24 | leukocyte aggregation (GO:0070486) | 3.77145961 |
| 25 | neutrophil activation (GO:0042119) | 3.75809574 |
| 26 | NIK/NF-kappaB signaling (GO:0038061) | 3.75692345 |
| 27 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.75589503 |
| 28 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.75065418 |
| 29 | response to host (GO:0075136) | 3.75065418 |
| 30 | response to host defenses (GO:0052200) | 3.75065418 |
| 31 | positive regulation of mast cell activation (GO:0033005) | 3.73676313 |
| 32 | positive regulation of antigen processing and presentation (GO:0002579) | 3.71747377 |
| 33 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.71247092 |
| 34 | negative regulation of T cell mediated immunity (GO:0002710) | 3.69228637 |
| 35 | regulation of mast cell degranulation (GO:0043304) | 3.68331022 |
| 36 | positive regulation of B cell differentiation (GO:0045579) | 3.68066554 |
| 37 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.66993279 |
| 38 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.66888339 |
| 39 | neutrophil activation involved in immune response (GO:0002283) | 3.66862794 |
| 40 | regulation of B cell differentiation (GO:0045577) | 3.58710436 |
| 41 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.57050474 |
| 42 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.50225531 |
| 43 | T cell migration (GO:0072678) | 3.48690781 |
| 44 | positive thymic T cell selection (GO:0045059) | 3.47876615 |
| 45 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.46263189 |
| 46 | myeloid leukocyte mediated immunity (GO:0002444) | 3.43814686 |
| 47 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.43740303 |
| 48 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.42956270 |
| 49 | mast cell activation (GO:0045576) | 3.40613059 |
| 50 | regulation of mast cell activation (GO:0033003) | 3.40432889 |
| 51 | modulation by symbiont of host immune response (GO:0052553) | 3.40391001 |
| 52 | positive regulation by symbiont of host defense response (GO:0052509) | 3.40391001 |
| 53 | modulation by symbiont of host defense response (GO:0052031) | 3.40391001 |
| 54 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.40391001 |
| 55 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.40391001 |
| 56 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.40391001 |
| 57 | thymic T cell selection (GO:0045061) | 3.40154377 |
| 58 | granulocyte activation (GO:0036230) | 3.39768457 |
| 59 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.39387822 |
| 60 | regulation of gamma-delta T cell activation (GO:0046643) | 3.38996229 |
| 61 | T cell selection (GO:0045058) | 3.38485449 |
| 62 | regulation of T cell tolerance induction (GO:0002664) | 3.33455257 |
| 63 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.33389899 |
| 64 | regulation of leukocyte degranulation (GO:0043300) | 3.33262504 |
| 65 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.30859494 |
| 66 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.29244646 |
| 67 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.28711191 |
| 68 | positive regulation of mast cell degranulation (GO:0043306) | 3.28711191 |
| 69 | myeloid dendritic cell activation (GO:0001773) | 3.24936142 |
| 70 | response to interleukin-15 (GO:0070672) | 3.23840430 |
| 71 | cellular response to interleukin-15 (GO:0071350) | 3.19760410 |
| 72 | mature B cell differentiation (GO:0002335) | 3.16522441 |
| 73 | macrophage activation involved in immune response (GO:0002281) | 3.15419403 |
| 74 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.13900322 |
| 75 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.13116777 |
| 76 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.11259926 |
| 77 | myeloid cell activation involved in immune response (GO:0002275) | 3.10324468 |
| 78 | regulation of antigen processing and presentation (GO:0002577) | 3.08622707 |
| 79 | myeloid dendritic cell differentiation (GO:0043011) | 3.08412229 |
| 80 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.07477789 |
| 81 | positive T cell selection (GO:0043368) | 3.06515868 |
| 82 | germinal center formation (GO:0002467) | 3.04227899 |
| 83 | cellular extravasation (GO:0045123) | 3.03111214 |
| 84 | regulation of regulated secretory pathway (GO:1903305) | 3.00818890 |
| 85 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.00232484 |
| 86 | regulation of macrophage cytokine production (GO:0010935) | 2.99425177 |
| 87 | response to muramyl dipeptide (GO:0032495) | 2.98674054 |
| 88 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.97587100 |
| 89 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.95040973 |
| 90 | B cell homeostasis (GO:0001782) | 2.94952629 |
| 91 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.93387427 |
| 92 | mast cell activation involved in immune response (GO:0002279) | 2.93133757 |
| 93 | mast cell degranulation (GO:0043303) | 2.93133757 |
| 94 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.92051032 |
| 95 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.90054982 |
| 96 | microglial cell activation (GO:0001774) | 2.89985250 |
| 97 | negative regulation of type 2 immune response (GO:0002829) | 2.88252905 |
| 98 | response to peptidoglycan (GO:0032494) | 2.88200667 |
| 99 | positive regulation of macrophage cytokine production (GO:0060907) | 2.88065369 |
| 100 | respiratory burst (GO:0045730) | 2.85198777 |
| 101 | myeloid leukocyte activation (GO:0002274) | 2.84140568 |
| 102 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.83940154 |
| 103 | neutrophil chemotaxis (GO:0030593) | 2.82492451 |
| 104 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.82030295 |
| 105 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.82030295 |
| 106 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.81871893 |
| 107 | tolerance induction (GO:0002507) | 2.81846668 |
| 108 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.81751507 |
| 109 | negative regulation of granulocyte differentiation (GO:0030853) | 2.81516405 |
| 110 | immunoglobulin mediated immune response (GO:0016064) | 2.80969738 |
| 111 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.76215663 |
| 112 | positive regulation of interleukin-2 production (GO:0032743) | 2.75595341 |
| 113 | negative regulation of phagocytosis (GO:0050765) | 2.75216886 |
| 114 | activated T cell proliferation (GO:0050798) | 2.74773834 |
| 115 | dendritic cell chemotaxis (GO:0002407) | 2.74228335 |
| 116 | T cell costimulation (GO:0031295) | 2.73576027 |
| 117 | interferon-gamma production (GO:0032609) | 2.71832816 |
| 118 | regulation of tolerance induction (GO:0002643) | 2.71119716 |
| 119 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.70761265 |
| 120 | dendritic cell differentiation (GO:0097028) | 2.69868011 |
| 121 | lymphocyte homeostasis (GO:0002260) | 2.69865242 |
| 122 | dendritic cell migration (GO:0036336) | 2.69570243 |
| 123 | lymphocyte costimulation (GO:0031294) | 2.68852691 |
| 124 | growth hormone receptor signaling pathway (GO:0060396) | 2.67351559 |
| 125 | positive regulation of interferon-alpha production (GO:0032727) | 2.66513213 |
| 126 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.65551546 |
| 127 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.65482752 |
| 128 | megakaryocyte development (GO:0035855) | 2.64806423 |
| 129 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.64195466 |
| 130 | response to type I interferon (GO:0034340) | 2.62334786 |
| 131 | T cell receptor signaling pathway (GO:0050852) | 2.61390979 |
| 132 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.60935119 |
| 133 | cellular response to zinc ion (GO:0071294) | 2.60678839 |
| 134 | type I interferon signaling pathway (GO:0060337) | 2.59948960 |
| 135 | cellular response to type I interferon (GO:0071357) | 2.59948960 |
| 136 | positive regulation of chemokine secretion (GO:0090197) | 2.59212740 |
| 137 | leukocyte degranulation (GO:0043299) | 2.58488725 |
| 138 | neutrophil mediated immunity (GO:0002446) | 2.58248695 |
| 139 | defense response to protozoan (GO:0042832) | 2.57925651 |
| 140 | natural killer cell differentiation (GO:0001779) | 2.57557669 |
| 141 | T cell homeostasis (GO:0043029) | 2.54261678 |
| 142 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.52801504 |
| 143 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.52723655 |
| 144 | natural killer cell activation (GO:0030101) | 2.52370173 |
| 145 | hepatocyte apoptotic process (GO:0097284) | 2.51239017 |
| 146 | regulation of interferon-alpha production (GO:0032647) | 2.50959363 |
| 147 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.50110190 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.53841083 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.85925465 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.67282719 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.41809534 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.48607702 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.45937590 |
| 7 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.36614215 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.32814157 |
| 9 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.25133017 |
| 10 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 3.18373390 |
| 11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.13637341 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.91230637 |
| 13 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.81860831 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.69300401 |
| 15 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.66885911 |
| 16 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.64717560 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.42041504 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.31355281 |
| 19 | MYB_26560356_Chip-Seq_TH2_Human | 2.21577939 |
| 20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.16428080 |
| 21 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.15460319 |
| 22 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.13830661 |
| 23 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.06308078 |
| 24 | SPI1_23127762_ChIP-Seq_K562_Human | 2.05558180 |
| 25 | MAF_26560356_Chip-Seq_TH1_Human | 1.99983378 |
| 26 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.93068583 |
| 27 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.92415617 |
| 28 | MYB_26560356_Chip-Seq_TH1_Human | 1.83597493 |
| 29 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.80260479 |
| 30 | * MYC_22102868_ChIP-Seq_BL_Human | 1.75271500 |
| 31 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.74978806 |
| 32 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.70870946 |
| 33 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.70002253 |
| 34 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.68199721 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.67181202 |
| 36 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.65361877 |
| 37 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.64590878 |
| 38 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62972361 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.62385653 |
| 40 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.62096735 |
| 41 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.61283191 |
| 42 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.58370935 |
| 43 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.57990047 |
| 44 | UTX_26944678_Chip-Seq_JUKART_Human | 1.57232529 |
| 45 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.55743648 |
| 46 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.51134252 |
| 47 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.50197607 |
| 48 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.46948737 |
| 49 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45376383 |
| 50 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.38317912 |
| 51 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.32751382 |
| 52 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31575249 |
| 53 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.30500611 |
| 54 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25508055 |
| 55 | GATA1_22025678_ChIP-Seq_K562_Human | 1.22866667 |
| 56 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22249945 |
| 57 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.18771559 |
| 58 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.17608135 |
| 59 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16181162 |
| 60 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.14894100 |
| 61 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.14450312 |
| 62 | MAF_26560356_Chip-Seq_TH2_Human | 1.13336411 |
| 63 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12434605 |
| 64 | GATA3_26560356_Chip-Seq_TH2_Human | 1.12329812 |
| 65 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.08473558 |
| 66 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.06169675 |
| 67 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.03010084 |
| 68 | GATA1_19941826_ChIP-Seq_K562_Human | 1.00211421 |
| 69 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99582742 |
| 70 | GATA2_19941826_ChIP-Seq_K562_Human | 0.99452226 |
| 71 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98125957 |
| 72 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.95867597 |
| 73 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95488572 |
| 74 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95210668 |
| 75 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93110730 |
| 76 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.91456274 |
| 77 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.89334666 |
| 78 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.89169617 |
| 79 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.88789007 |
| 80 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87435684 |
| 81 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86484641 |
| 82 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.85790306 |
| 83 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82878809 |
| 84 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.81752735 |
| 85 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.81396970 |
| 86 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.80429865 |
| 87 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.79457650 |
| 88 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.78766168 |
| 89 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.76280928 |
| 90 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.74345120 |
| 91 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.71727028 |
| 92 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.71007457 |
| 93 | KDM2B_26808549_Chip-Seq_K562_Human | 0.69895921 |
| 94 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.68778612 |
| 95 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.68181489 |
| 96 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.67967803 |
| 97 | RXR_22108803_ChIP-Seq_LS180_Human | 0.67959158 |
| 98 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.67571831 |
| 99 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.67322937 |
| 100 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.66545905 |
| 101 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.65416404 |
| 102 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.64814258 |
| 103 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.63680414 |
| 104 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.62576794 |
| 105 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.62535731 |
| 106 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.62245348 |
| 107 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.62128608 |
| 108 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.61448162 |
| 109 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.60112803 |
| 110 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.58434256 |
| 111 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.57812981 |
| 112 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.57644402 |
| 113 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.56259883 |
| 114 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.55027007 |
| 115 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.54692967 |
| 116 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.54166838 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.48360986 |
| 2 | MP0000685_abnormal_immune_system | 3.43377479 |
| 3 | MP0005387_immune_system_phenotype | 3.38467306 |
| 4 | MP0001790_abnormal_immune_system | 3.38467306 |
| 5 | MP0005671_abnormal_response_to | 3.35481513 |
| 6 | MP0001800_abnormal_humoral_immune | 3.11746203 |
| 7 | MP0005000_abnormal_immune_tolerance | 2.91096909 |
| 8 | MP0002452_abnormal_antigen_presenting | 2.87253038 |
| 9 | MP0002419_abnormal_innate_immunity | 2.70444685 |
| 10 | MP0002723_abnormal_immune_serum | 2.66940168 |
| 11 | MP0002420_abnormal_adaptive_immunity | 2.64232822 |
| 12 | MP0001819_abnormal_immune_cell | 2.61894788 |
| 13 | MP0002148_abnormal_hypersensitivity_rea | 2.61460993 |
| 14 | MP0003436_decreased_susceptibility_to | 2.57849026 |
| 15 | MP0003763_abnormal_thymus_physiology | 2.55568526 |
| 16 | MP0003303_peritoneal_inflammation | 2.46514838 |
| 17 | MP0002166_altered_tumor_susceptibility | 2.46456164 |
| 18 | MP0005025_abnormal_response_to | 2.39588459 |
| 19 | MP0009785_altered_susceptibility_to | 2.32555629 |
| 20 | MP0000569_abnormal_digit_pigmentation | 2.28171826 |
| 21 | MP0004510_myositis | 2.21111481 |
| 22 | MP0002398_abnormal_bone_marrow | 2.18085659 |
| 23 | MP0006082_CNS_inflammation | 2.15738051 |
| 24 | MP0000716_abnormal_immune_system | 2.13300165 |
| 25 | MP0005464_abnormal_platelet_physiology | 2.05066988 |
| 26 | MP0005058_abnormal_lysosome_morphology | 2.02638576 |
| 27 | MP0002396_abnormal_hematopoietic_system | 2.00074597 |
| 28 | MP0003828_pulmonary_edema | 1.96412239 |
| 29 | MP0002006_tumorigenesis | 1.96086875 |
| 30 | MP0003300_gastrointestinal_ulcer | 1.90322317 |
| 31 | MP0005310_abnormal_salivary_gland | 1.86333984 |
| 32 | MP0003172_abnormal_lysosome_physiology | 1.85661645 |
| 33 | MP0002405_respiratory_system_inflammati | 1.81915531 |
| 34 | MP0003183_abnormal_peptide_metabolism | 1.74180033 |
| 35 | MP0000920_abnormal_myelination | 1.70716956 |
| 36 | MP0002254_reproductive_system_inflammat | 1.70372410 |
| 37 | MP0003690_abnormal_glial_cell | 1.70105911 |
| 38 | MP0000689_abnormal_spleen_morphology | 1.69214999 |
| 39 | MP0005174_abnormal_tail_pigmentation | 1.67884539 |
| 40 | MP0001873_stomach_inflammation | 1.64708684 |
| 41 | MP0002429_abnormal_blood_cell | 1.62995346 |
| 42 | MP0002722_abnormal_immune_system | 1.59856107 |
| 43 | MP0000465_gastrointestinal_hemorrhage | 1.58904224 |
| 44 | MP0004883_abnormal_blood_vessel | 1.58203631 |
| 45 | MP0010155_abnormal_intestine_physiology | 1.54660889 |
| 46 | MP0003724_increased_susceptibility_to | 1.53766175 |
| 47 | MP0002009_preneoplasia | 1.52976874 |
| 48 | MP0004808_abnormal_hematopoietic_stem | 1.51134318 |
| 49 | MP0000015_abnormal_ear_pigmentation | 1.48405854 |
| 50 | MP0001845_abnormal_inflammatory_respons | 1.46663420 |
| 51 | MP0000703_abnormal_thymus_morphology | 1.46176739 |
| 52 | MP0001533_abnormal_skeleton_physiology | 1.42732012 |
| 53 | MP0004947_skin_inflammation | 1.40871347 |
| 54 | MP0009278_abnormal_bone_marrow | 1.36371416 |
| 55 | MP0002132_abnormal_respiratory_system | 1.34168076 |
| 56 | MP0009333_abnormal_splenocyte_physiolog | 1.32670989 |
| 57 | MP0002933_joint_inflammation | 1.28899893 |
| 58 | MP0001853_heart_inflammation | 1.28872004 |
| 59 | MP0002277_abnormal_respiratory_mucosa | 1.23351779 |
| 60 | MP0005451_abnormal_body_composition | 1.22803469 |
| 61 | MP0002998_abnormal_bone_remodeling | 1.20409636 |
| 62 | MP0001851_eye_inflammation | 1.16979538 |
| 63 | MP0003191_abnormal_cellular_cholesterol | 1.15485279 |
| 64 | MP0002138_abnormal_hepatobiliary_system | 1.14445608 |
| 65 | MP0003329_amyloid_beta_deposits | 1.13877894 |
| 66 | MP0005164_abnormal_response_to | 1.04967134 |
| 67 | MP0003448_altered_tumor_morphology | 1.03681942 |
| 68 | MP0003656_abnormal_erythrocyte_physiolo | 1.02298517 |
| 69 | MP0003866_abnormal_defecation | 1.01027231 |
| 70 | MP0001348_abnormal_lacrimal_gland | 1.00790459 |
| 71 | MP0003045_fibrosis | 0.99296061 |
| 72 | MP0003075_altered_response_to | 0.99227676 |
| 73 | MP0005397_hematopoietic_system_phenotyp | 0.97807018 |
| 74 | MP0001545_abnormal_hematopoietic_system | 0.97807018 |
| 75 | MP0005167_abnormal_blood-brain_barrier | 0.96587843 |
| 76 | MP0004130_abnormal_muscle_cell | 0.94904056 |
| 77 | MP0002095_abnormal_skin_pigmentation | 0.94682566 |
| 78 | MP0008469_abnormal_protein_level | 0.92683813 |
| 79 | MP0003091_abnormal_cell_migration | 0.87571583 |
| 80 | MP0005075_abnormal_melanosome_morpholog | 0.85882869 |
| 81 | MP0000604_amyloidosis | 0.82951684 |
| 82 | MP0005388_respiratory_system_phenotype | 0.81418610 |
| 83 | MP0002133_abnormal_respiratory_system | 0.81418610 |
| 84 | MP0008569_lethality_at_weaning | 0.79743539 |
| 85 | MP0001346_abnormal_lacrimal_gland | 0.78055421 |
| 86 | MP0003221_abnormal_cardiomyocyte_apopto | 0.74693435 |
| 87 | MP0009763_increased_sensitivity_to | 0.73361618 |
| 88 | MP0004742_abnormal_vestibular_system | 0.73134863 |
| 89 | MP0009764_decreased_sensitivity_to | 0.72210714 |
| 90 | MP0001958_emphysema | 0.70589985 |
| 91 | MP0003633_abnormal_nervous_system | 0.68867199 |
| 92 | MP0000343_altered_response_to | 0.68390920 |
| 93 | MP0009765_abnormal_xenobiotic_induced | 0.67613731 |
| 94 | MP0000858_altered_metastatic_potential | 0.67561235 |
| 95 | MP0003453_abnormal_keratinocyte_physiol | 0.66903583 |
| 96 | MP0004381_abnormal_hair_follicle | 0.66811675 |
| 97 | MP0003787_abnormal_imprinting | 0.66360046 |
| 98 | MP0001663_abnormal_digestive_system | 0.65622760 |
| 99 | MP0005166_decreased_susceptibility_to | 0.63108977 |
| 100 | MP0002163_abnormal_gland_morphology | 0.61775443 |
| 101 | MP0005171_absent_coat_pigmentation | 0.59645555 |
| 102 | MP0008260_abnormal_autophagy | 0.59081024 |
| 103 | MP0000490_abnormal_crypts_of | 0.59049068 |
| 104 | MP0002332_abnormal_exercise_endurance | 0.58910939 |
| 105 | MP0004484_altered_response_of | 0.58569658 |
| 106 | MP0003279_aneurysm | 0.58441753 |
| 107 | MP0005390_skeleton_phenotype | 0.58135247 |
| 108 | MP0003632_abnormal_nervous_system | 0.57120327 |
| 109 | MP0000249_abnormal_blood_vessel | 0.56974737 |
| 110 | MP0005409_darkened_coat_color | 0.55536867 |
| 111 | MP0003634_abnormal_glial_cell | 0.55336873 |
| 112 | MP0006054_spinal_hemorrhage | 0.55317128 |
| 113 | MP0008874_decreased_physiological_sensi | 0.53948195 |
| 114 | MP0003795_abnormal_bone_structure | 0.53934447 |
| 115 | MP0000371_diluted_coat_color | 0.53855972 |
| 116 | MP0000767_abnormal_smooth_muscle | 0.52814251 |
| 117 | MP0005645_abnormal_hypothalamus_physiol | 0.51382963 |
| 118 | MP0000383_abnormal_hair_follicle | 0.48396580 |
| 119 | MP0003631_nervous_system_phenotype | 0.46994653 |
| 120 | MP0001986_abnormal_taste_sensitivity | 0.46556639 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.13893432 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 4.79420354 |
| 3 | Agammaglobulinemia (HP:0004432) | 4.58509661 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.44554847 |
| 5 | Recurrent fungal infections (HP:0002841) | 4.28348669 |
| 6 | Chronic otitis media (HP:0000389) | 4.28290395 |
| 7 | Cellulitis (HP:0100658) | 4.21856575 |
| 8 | Recurrent viral infections (HP:0004429) | 4.20271026 |
| 9 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.02748722 |
| 10 | Recurrent cutaneous fungal infections (HP:0011370) | 4.02748722 |
| 11 | Gastrointestinal infarctions (HP:0005244) | 3.99588748 |
| 12 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.95430178 |
| 13 | Recurrent skin infections (HP:0001581) | 3.78337083 |
| 14 | Keratoconjunctivitis sicca (HP:0001097) | 3.75671562 |
| 15 | Panhypogammaglobulinemia (HP:0003139) | 3.73767142 |
| 16 | Keratoconjunctivitis (HP:0001096) | 3.47143093 |
| 17 | Meningitis (HP:0001287) | 3.42372012 |
| 18 | Inflammation of the large intestine (HP:0002037) | 3.35092550 |
| 19 | Colitis (HP:0002583) | 3.34205227 |
| 20 | Myositis (HP:0100614) | 3.33322209 |
| 21 | Mediastinal lymphadenopathy (HP:0100721) | 3.30987724 |
| 22 | Urticaria (HP:0001025) | 3.18758396 |
| 23 | Abnormality of T cell number (HP:0011839) | 3.15977978 |
| 24 | Recurrent bronchitis (HP:0002837) | 3.11605171 |
| 25 | T lymphocytopenia (HP:0005403) | 3.10138218 |
| 26 | Gastrointestinal inflammation (HP:0004386) | 3.09775937 |
| 27 | Obstructive lung disease (HP:0006536) | 3.03112352 |
| 28 | Chronic obstructive pulmonary disease (HP:0006510) | 3.03112352 |
| 29 | Abnormality of macrophages (HP:0004311) | 3.00281804 |
| 30 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.94393976 |
| 31 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.89413955 |
| 32 | Eosinophilia (HP:0001880) | 2.88101095 |
| 33 | Episodic fever (HP:0001954) | 2.84883558 |
| 34 | Hypochromic microcytic anemia (HP:0004840) | 2.83810986 |
| 35 | Spontaneous hematomas (HP:0007420) | 2.83799128 |
| 36 | Amyloidosis (HP:0011034) | 2.83293394 |
| 37 | Vasculitis (HP:0002633) | 2.82846925 |
| 38 | Optic neuritis (HP:0100653) | 2.80481441 |
| 39 | Retrobulbar optic neuritis (HP:0100654) | 2.80481441 |
| 40 | Peritonitis (HP:0002586) | 2.78752769 |
| 41 | Systemic lupus erythematosus (HP:0002725) | 2.76027255 |
| 42 | Stomatitis (HP:0010280) | 2.73891581 |
| 43 | Thyroiditis (HP:0100646) | 2.61205772 |
| 44 | Chronic diarrhea (HP:0002028) | 2.58209598 |
| 45 | Hypochromic anemia (HP:0001931) | 2.54486901 |
| 46 | Orchitis (HP:0100796) | 2.52997403 |
| 47 | Gastrointestinal stroma tumor (HP:0100723) | 2.52454594 |
| 48 | IgM deficiency (HP:0002850) | 2.52253011 |
| 49 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.51131599 |
| 50 | Lymphopenia (HP:0001888) | 2.49460522 |
| 51 | Epistaxis (HP:0000421) | 2.48813180 |
| 52 | Abnormality of T cells (HP:0002843) | 2.48080346 |
| 53 | Osteomyelitis (HP:0002754) | 2.47963568 |
| 54 | Hemiplegia (HP:0002301) | 2.47684537 |
| 55 | Papilloma (HP:0012740) | 2.47177819 |
| 56 | Verrucae (HP:0200043) | 2.47177819 |
| 57 | Autoimmune thrombocytopenia (HP:0001973) | 2.46601136 |
| 58 | Hematochezia (HP:0002573) | 2.45885818 |
| 59 | Leukocytosis (HP:0001974) | 2.44123704 |
| 60 | Abnormality of the fingertips (HP:0001211) | 2.44050555 |
| 61 | Recurrent pneumonia (HP:0006532) | 2.44043698 |
| 62 | Abnormality of eosinophils (HP:0001879) | 2.43340283 |
| 63 | Increased cerebral lipofuscin (HP:0011813) | 2.43064877 |
| 64 | Fatigue (HP:0012378) | 2.42986335 |
| 65 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.40360272 |
| 66 | Increased IgE level (HP:0003212) | 2.35972708 |
| 67 | Recurrent lower respiratory tract infections (HP:0002783) | 2.35572134 |
| 68 | Gingivitis (HP:0000230) | 2.34652894 |
| 69 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.34286179 |
| 70 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.34286179 |
| 71 | Abnormality of glycolipid metabolism (HP:0010969) | 2.34286179 |
| 72 | Pulmonary infiltrates (HP:0002113) | 2.33831220 |
| 73 | Periodontitis (HP:0000704) | 2.33253776 |
| 74 | Granulocytopenia (HP:0001913) | 2.32413411 |
| 75 | Slow saccadic eye movements (HP:0000514) | 2.32066176 |
| 76 | Chronic sinusitis (HP:0011109) | 2.30996449 |
| 77 | Prolonged bleeding time (HP:0003010) | 2.27226267 |
| 78 | Subacute progressive viral hepatitis (HP:0006572) | 2.27160010 |
| 79 | Anorexia (HP:0002039) | 2.26877555 |
| 80 | Abnormality of the pleura (HP:0002103) | 2.26563938 |
| 81 | Abnormality of the peritoneum (HP:0002585) | 2.22856870 |
| 82 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.22204842 |
| 83 | Gangrene (HP:0100758) | 2.20753728 |
| 84 | Abnormality of the endocardium (HP:0004306) | 2.19765931 |
| 85 | Pustule (HP:0200039) | 2.18904359 |
| 86 | Arterial thrombosis (HP:0004420) | 2.18698904 |
| 87 | Vertigo (HP:0002321) | 2.15521661 |
| 88 | Absent frontal sinuses (HP:0002688) | 2.15385031 |
| 89 | Encephalitis (HP:0002383) | 2.14851194 |
| 90 | Recurrent sinusitis (HP:0011108) | 2.13574474 |
| 91 | Interstitial pulmonary disease (HP:0006530) | 2.11629226 |
| 92 | Loss of speech (HP:0002371) | 2.10825304 |
| 93 | Dysostosis multiplex (HP:0000943) | 2.10498182 |
| 94 | Sepsis (HP:0100806) | 2.09949605 |
| 95 | Nasal polyposis (HP:0100582) | 2.08347070 |
| 96 | Microcytic anemia (HP:0001935) | 2.08026968 |
| 97 | Gingival bleeding (HP:0000225) | 2.07343185 |
| 98 | Glomerulonephritis (HP:0000099) | 2.05109920 |
| 99 | Increased IgM level (HP:0003496) | 2.03641829 |
| 100 | Osteolytic defects of the hand bones (HP:0009699) | 2.00200598 |
| 101 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.00200598 |
| 102 | Abnormality of T cell physiology (HP:0011840) | 2.00155002 |
| 103 | Emphysema (HP:0002097) | 1.98328403 |
| 104 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.98083698 |
| 105 | Pulmonary embolism (HP:0002204) | 1.97095166 |
| 106 | Hemoptysis (HP:0002105) | 1.94452414 |
| 107 | Supranuclear gaze palsy (HP:0000605) | 1.94403658 |
| 108 | Chest pain (HP:0100749) | 1.94367094 |
| 109 | IgG deficiency (HP:0004315) | 1.93144326 |
| 110 | Hypergammaglobulinemia (HP:0010702) | 1.92763709 |
| 111 | Glomerulopathy (HP:0100820) | 1.91021394 |
| 112 | B lymphocytopenia (HP:0010976) | 1.89995338 |
| 113 | Abnormality of B cell number (HP:0010975) | 1.89995338 |
| 114 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.86641588 |
| 115 | Thrombocytosis (HP:0001894) | 1.86547654 |
| 116 | Restrictive lung disease (HP:0002091) | 1.84972537 |
| 117 | Skin ulcer (HP:0200042) | 1.84758540 |
| 118 | Persistence of primary teeth (HP:0006335) | 1.83806189 |
| 119 | Stomach cancer (HP:0012126) | 1.82471520 |
| 120 | Polyneuropathy (HP:0001271) | 1.82083922 |
| 121 | Viral hepatitis (HP:0006562) | 1.80995693 |
| 122 | Keratitis (HP:0000491) | 1.80514921 |
| 123 | Postural instability (HP:0002172) | 1.79827339 |
| 124 | Prostate neoplasm (HP:0100787) | 1.79070275 |
| 125 | Disinhibition (HP:0000734) | 1.78897205 |
| 126 | Increased CSF protein (HP:0002922) | 1.78792031 |
| 127 | Difficulty running (HP:0009046) | 1.77925569 |
| 128 | Papilledema (HP:0001085) | 1.77078959 |
| 129 | Abnormality of the prostate (HP:0008775) | 1.77049297 |
| 130 | Diplopia (HP:0000651) | 1.75231175 |
| 131 | Abnormality of binocular vision (HP:0011514) | 1.75231175 |
| 132 | Acne (HP:0001061) | 1.74074973 |
| 133 | Amaurosis fugax (HP:0100576) | 1.73526993 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.95292610 |
| 2 | MAP3K14 | 3.21897673 |
| 3 | TYK2 | 2.94387953 |
| 4 | IRAK4 | 2.63275137 |
| 5 | MAP3K13 | 2.58658537 |
| 6 | EPHB1 | 2.54310535 |
| 7 | CSF1R | 2.53782054 |
| 8 | TXK | 2.41987325 |
| 9 | JAK3 | 2.41700582 |
| 10 | JAK1 | 2.36417726 |
| 11 | KIT | 2.30067566 |
| 12 | TGFBR2 | 2.22553492 |
| 13 | IKBKE | 2.16314171 |
| 14 | BLK | 2.15286859 |
| 15 | IKBKB | 1.92509653 |
| 16 | RIPK4 | 1.91899976 |
| 17 | CLK1 | 1.89301876 |
| 18 | BTK | 1.89150250 |
| 19 | ITK | 1.87418931 |
| 20 | ERN1 | 1.86563393 |
| 21 | FES | 1.80370245 |
| 22 | SYK | 1.73426108 |
| 23 | HCK | 1.65550689 |
| 24 | TBK1 | 1.64834220 |
| 25 | SIK2 | 1.62735569 |
| 26 | PKN1 | 1.58668369 |
| 27 | TEC | 1.54077557 |
| 28 | STK10 | 1.51803657 |
| 29 | FGFR3 | 1.51299466 |
| 30 | KSR2 | 1.48800728 |
| 31 | ZAP70 | 1.47416200 |
| 32 | LCK | 1.41113793 |
| 33 | TAOK1 | 1.39745102 |
| 34 | GRK6 | 1.36062221 |
| 35 | CSK | 1.30199156 |
| 36 | CHUK | 1.25188672 |
| 37 | MAP3K3 | 1.24950190 |
| 38 | CAMK1D | 1.23850230 |
| 39 | MAP3K1 | 1.22831843 |
| 40 | CAMK1G | 1.22565531 |
| 41 | FGFR4 | 1.22157251 |
| 42 | MAP3K11 | 1.13544379 |
| 43 | IRAK2 | 1.08189535 |
| 44 | PRKCQ | 1.07765682 |
| 45 | SIK3 | 1.03384708 |
| 46 | FGFR2 | 0.99768952 |
| 47 | LYN | 0.99055692 |
| 48 | FGR | 0.98832754 |
| 49 | TNK2 | 0.98123117 |
| 50 | MAP3K2 | 0.96724674 |
| 51 | PIK3CG | 0.95397046 |
| 52 | NLK | 0.95125783 |
| 53 | HIPK2 | 0.87889107 |
| 54 | JAK2 | 0.87576717 |
| 55 | SGK3 | 0.86823517 |
| 56 | PRPF4B | 0.86044380 |
| 57 | PRKCH | 0.83759576 |
| 58 | WNK1 | 0.82984616 |
| 59 | SGK223 | 0.80791809 |
| 60 | SGK494 | 0.80791809 |
| 61 | BMPR2 | 0.80505022 |
| 62 | RIPK1 | 0.78935365 |
| 63 | EPHA3 | 0.78781905 |
| 64 | TRPM7 | 0.77631002 |
| 65 | KSR1 | 0.77431452 |
| 66 | MARK3 | 0.76434574 |
| 67 | MAP2K4 | 0.76319583 |
| 68 | CAMKK1 | 0.75357192 |
| 69 | MAP3K6 | 0.73715390 |
| 70 | MAPKAPK5 | 0.73338485 |
| 71 | SGK2 | 0.73005599 |
| 72 | MAPK15 | 0.72545439 |
| 73 | LRRK2 | 0.70290808 |
| 74 | PTK2B | 0.69462764 |
| 75 | CDK19 | 0.69116979 |
| 76 | PDPK1 | 0.69040607 |
| 77 | IRAK3 | 0.67941267 |
| 78 | RAF1 | 0.66624275 |
| 79 | EEF2K | 0.65569186 |
| 80 | DAPK2 | 0.64147072 |
| 81 | PIM1 | 0.64125584 |
| 82 | GRK7 | 0.62433146 |
| 83 | PDGFRB | 0.61463310 |
| 84 | DMPK | 0.60794220 |
| 85 | MAPK12 | 0.57584845 |
| 86 | MAPKAPK2 | 0.57164773 |
| 87 | MAPK7 | 0.55923134 |
| 88 | STK4 | 0.55905462 |
| 89 | ADRBK2 | 0.54865438 |
| 90 | FYN | 0.53870518 |
| 91 | PRKD1 | 0.51294829 |
| 92 | MAP3K5 | 0.51158746 |
| 93 | PDK1 | 0.50664020 |
| 94 | ALK | 0.49822973 |
| 95 | PRKAA2 | 0.48759963 |
| 96 | PRKD2 | 0.48310266 |
| 97 | MARK2 | 0.48308087 |
| 98 | TAOK3 | 0.47052804 |
| 99 | RPS6KA6 | 0.46813962 |
| 100 | YES1 | 0.46139990 |
| 101 | DYRK1B | 0.46019231 |
| 102 | MAP3K10 | 0.45582312 |
| 103 | ABL1 | 0.45516758 |
| 104 | TAOK2 | 0.44223592 |
| 105 | PRKCD | 0.44090447 |
| 106 | STK38 | 0.40887640 |
| 107 | CAMK4 | 0.40562937 |
| 108 | MATK | 0.40376106 |
| 109 | STK11 | 0.40320452 |
| 110 | PRKCZ | 0.40089774 |
| 111 | TRIB3 | 0.40083811 |
| 112 | SGK1 | 0.39920351 |
| 113 | NEK9 | 0.37246869 |
| 114 | CDC42BPA | 0.36942534 |
| 115 | CDK12 | 0.36399061 |
| 116 | IRAK1 | 0.36220162 |
| 117 | CAMKK2 | 0.34435695 |
| 118 | NTRK3 | 0.33462564 |
| 119 | RPS6KA5 | 0.33450547 |
| 120 | MAP2K3 | 0.33293691 |
| 121 | RPS6KC1 | 0.32406414 |
| 122 | RPS6KL1 | 0.32406414 |
| 123 | RET | 0.31980805 |
| 124 | MAP3K7 | 0.31175483 |
| 125 | PTK6 | 0.31095240 |
| 126 | EGFR | 0.28500181 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.85713216 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.54984177 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.32750612 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.29029064 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.25673354 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.16371027 |
| 7 | Measles_Homo sapiens_hsa05162 | 1.89605658 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.87396544 |
| 9 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.80446362 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.79437447 |
| 11 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.79229641 |
| 12 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.77062347 |
| 13 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.73982442 |
| 14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.55894492 |
| 15 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.54407194 |
| 16 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.50118547 |
| 17 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.48687082 |
| 18 | Allograft rejection_Homo sapiens_hsa05330 | 1.46386082 |
| 19 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.42491508 |
| 20 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.40997991 |
| 21 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.40200845 |
| 22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.39831597 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.39702811 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.39436858 |
| 25 | Pertussis_Homo sapiens_hsa05133 | 1.37081397 |
| 26 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.31974622 |
| 27 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.30294749 |
| 28 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.28681126 |
| 29 | Influenza A_Homo sapiens_hsa05164 | 1.25034941 |
| 30 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.20734899 |
| 31 | Apoptosis_Homo sapiens_hsa04210 | 1.17366451 |
| 32 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.15480128 |
| 33 | Platelet activation_Homo sapiens_hsa04611 | 1.13045189 |
| 34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.12923766 |
| 35 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.12644155 |
| 36 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.12317887 |
| 37 | Lysosome_Homo sapiens_hsa04142 | 1.11641473 |
| 38 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.09680784 |
| 39 | Other glycan degradation_Homo sapiens_hsa00511 | 1.09668020 |
| 40 | Malaria_Homo sapiens_hsa05144 | 1.08798803 |
| 41 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.05952565 |
| 42 | Salmonella infection_Homo sapiens_hsa05132 | 1.05567087 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 1.04977111 |
| 44 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.03937405 |
| 45 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.02648150 |
| 46 | Shigellosis_Homo sapiens_hsa05131 | 1.02030002 |
| 47 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.01835007 |
| 48 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.01378756 |
| 49 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.99484867 |
| 50 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.98089879 |
| 51 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.96322767 |
| 52 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.96101922 |
| 53 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.95876426 |
| 54 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.93146456 |
| 55 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.92049043 |
| 56 | Viral myocarditis_Homo sapiens_hsa05416 | 0.91695010 |
| 57 | Endometrial cancer_Homo sapiens_hsa05213 | 0.91693354 |
| 58 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.88563045 |
| 59 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.86063457 |
| 60 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.86020768 |
| 61 | Hepatitis C_Homo sapiens_hsa05160 | 0.85611291 |
| 62 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.83314744 |
| 63 | Endocytosis_Homo sapiens_hsa04144 | 0.83043235 |
| 64 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.82652535 |
| 65 | Colorectal cancer_Homo sapiens_hsa05210 | 0.82185934 |
| 66 | Long-term potentiation_Homo sapiens_hsa04720 | 0.81083523 |
| 67 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.80720775 |
| 68 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.79938914 |
| 69 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.78121242 |
| 70 | Olfactory transduction_Homo sapiens_hsa04740 | 0.76433318 |
| 71 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.76165380 |
| 72 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.74016022 |
| 73 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.73553516 |
| 74 | Morphine addiction_Homo sapiens_hsa05032 | 0.72620749 |
| 75 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.72004540 |
| 76 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.71709708 |
| 77 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71328106 |
| 78 | Asthma_Homo sapiens_hsa05310 | 0.70924763 |
| 79 | Legionellosis_Homo sapiens_hsa05134 | 0.70423767 |
| 80 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.69979600 |
| 81 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.66279297 |
| 82 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.65983854 |
| 83 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.65781389 |
| 84 | Phagosome_Homo sapiens_hsa04145 | 0.65576206 |
| 85 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.65366345 |
| 86 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.65049357 |
| 87 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.63657632 |
| 88 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.63024660 |
| 89 | HTLV-I infection_Homo sapiens_hsa05166 | 0.59584760 |
| 90 | Amoebiasis_Homo sapiens_hsa05146 | 0.58922888 |
| 91 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.57255643 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57230277 |
| 93 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.56036633 |
| 94 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.55124330 |
| 95 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.54772595 |
| 96 | Renin secretion_Homo sapiens_hsa04924 | 0.54130414 |
| 97 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.53661557 |
| 98 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.52960535 |
| 99 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.52844524 |
| 100 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.52817755 |
| 101 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.52646645 |
| 102 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.51681279 |
| 103 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.51314739 |
| 104 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.50956312 |
| 105 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.50872466 |
| 106 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49714974 |
| 107 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.49670067 |
| 108 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.49419400 |
| 109 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48874989 |
| 110 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.47204683 |
| 111 | Pathways in cancer_Homo sapiens_hsa05200 | 0.47091716 |
| 112 | Glioma_Homo sapiens_hsa05214 | 0.46837945 |
| 113 | Long-term depression_Homo sapiens_hsa04730 | 0.45587318 |
| 114 | Prostate cancer_Homo sapiens_hsa05215 | 0.45528004 |
| 115 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.45379082 |

